Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Raj Shah to Adenocarcinoma

This is a "connection" page, showing publications Raj Shah has written about Adenocarcinoma.

 
Connection Strength
 
 
 
0.996
 
  1. Han S, Turkeltaub JA, Jonas D, Attwell AR, Duloy AM, Edmundowicz SA, Hammad HT, Wagh MS, Wani S, Shah RJ. The timing of recurrence after endoscopic papillectomy. Surg Endosc. 2024 Feb; 38(2):688-696.
    View in: PubMed
    Score: 0.569
  2. Han S, Tatman P, Mehrotra S, Wani S, Attwell AR, Edmundowicz SA, Brauer BC, Wagh MS, Hammad HT, Shah RJ. Combination of ERCP-Based Modalities Increases Diagnostic Yield for Biliary Strictures. Dig Dis Sci. 2021 04; 66(4):1276-1284.
    View in: PubMed
    Score: 0.111
  3. Machicado JD, Obuch JC, Goodman KA, Schefter TE, Frakes J, Hoffe S, Latifi K, Simon VC, Santangelo T, Ezekwe E, Edmundowicz SA, Brauer BC, Shah RJ, Hammad HT, Wagh MS, Attwell A, Han S, Klapman J, Wani S. Endoscopic Ultrasound Placement of Preloaded Fiducial Markers Shortens Procedure Time Compared to Back-Loaded Markers. Clin Gastroenterol Hepatol. 2019 12; 17(13):2749-2758.e2.
    View in: PubMed
    Score: 0.103
  4. El Hajj II, Brauer BC, Wani S, Fukami N, Attwell AR, Shah RJ. Role of per-oral pancreatoscopy in the evaluation of suspected?pancreatic duct neoplasia: a 13-year U.S. single-center experience. Gastrointest Endosc. 2017 Apr; 85(4):737-745.
    View in: PubMed
    Score: 0.085
  5. Ballonoff A, Kavanagh B, McCarter M, Kane M, Pearlman N, Nash R, Shah RJ, Raben D, Schefter TE. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol. 2008 Jun; 31(3):264-70.
    View in: PubMed
    Score: 0.049
  6. Schefter TE, Patel M, McCarter M, Kane M, Russ PD, Nash SR, Shah RJ, Mitchell JD. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2. Oncology (Williston Park). 2005 Jun; 19(7):830, 835-6, 838 passim.
    View in: PubMed
    Score: 0.039
  7. Schefter TE, Patel M, McCarter M, Kane M, Russ PD, Nash SR, Shah RJ, Mitchell JD. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1. Oncology (Williston Park). 2005 May; 19(6):775-8, 783-4, 788 passim.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)